ES2276425T3 - Composicion bilogicamente activa. - Google Patents

Composicion bilogicamente activa. Download PDF

Info

Publication number
ES2276425T3
ES2276425T3 ES97922252T ES97922252T ES2276425T3 ES 2276425 T3 ES2276425 T3 ES 2276425T3 ES 97922252 T ES97922252 T ES 97922252T ES 97922252 T ES97922252 T ES 97922252T ES 2276425 T3 ES2276425 T3 ES 2276425T3
Authority
ES
Spain
Prior art keywords
composition according
composition
weight
biologically active
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97922252T
Other languages
English (en)
Spanish (es)
Inventor
Ake Lindahl
Rickard Bryland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec AG filed Critical Jagotec AG
Application granted granted Critical
Publication of ES2276425T3 publication Critical patent/ES2276425T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES97922252T 1996-04-30 1997-04-29 Composicion bilogicamente activa. Expired - Lifetime ES2276425T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9601665 1996-04-30
SE9601665A SE9601665D0 (sv) 1996-04-30 1996-04-30 Biologically active composition

Publications (1)

Publication Number Publication Date
ES2276425T3 true ES2276425T3 (es) 2007-06-16

Family

ID=20402417

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97922252T Expired - Lifetime ES2276425T3 (es) 1996-04-30 1997-04-29 Composicion bilogicamente activa.

Country Status (12)

Country Link
US (1) US6979454B1 (cg-RX-API-DMAC10.html)
EP (1) EP0952819B1 (cg-RX-API-DMAC10.html)
JP (1) JP4283892B2 (cg-RX-API-DMAC10.html)
AT (1) ATE345777T1 (cg-RX-API-DMAC10.html)
AU (1) AU701720B2 (cg-RX-API-DMAC10.html)
CA (1) CA2251702C (cg-RX-API-DMAC10.html)
DE (1) DE69736985T2 (cg-RX-API-DMAC10.html)
ES (1) ES2276425T3 (cg-RX-API-DMAC10.html)
NZ (1) NZ332497A (cg-RX-API-DMAC10.html)
SE (1) SE9601665D0 (cg-RX-API-DMAC10.html)
WO (1) WO1997040818A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA973705B (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7595378B2 (en) 2001-06-13 2009-09-29 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
DK1871353T3 (da) * 2005-04-15 2011-04-04 Einstein Coll Med Vitamin k til forebyggelse eller behandling af hududslæt sekundært til anti-EGFR-terapi
US9428582B2 (en) * 2006-07-03 2016-08-30 Genmab A/S Method of treating rash in patients undergoing anti-EGFR therapy
ES2550481T3 (es) * 2007-08-16 2015-11-10 The University Of Chicago Resistencia a patógenos de plantas
US8815953B2 (en) * 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use
CA2738970A1 (en) * 2008-10-31 2010-05-06 Moberg Derma Ab Topical composition comprising a combination of at least two penetration enhancing agents
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8685381B2 (en) 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299828A (en) * 1979-05-31 1981-11-10 E. R. Squibb & Sons, Inc. Corticosteroid stick formulations
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
GB8629640D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
ATE107517T1 (de) * 1989-05-25 1994-07-15 Takeda Chemical Industries Ltd Transdermales therapeutisches mittel.

Also Published As

Publication number Publication date
NZ332497A (en) 1999-05-28
SE9601665D0 (sv) 1996-04-30
ATE345777T1 (de) 2006-12-15
CA2251702A1 (en) 1997-11-06
AU701720B2 (en) 1999-02-04
AU2796997A (en) 1997-11-19
JP2000509385A (ja) 2000-07-25
DE69736985T2 (de) 2007-09-20
CA2251702C (en) 2007-01-09
ZA973705B (en) 1997-11-25
JP4283892B2 (ja) 2009-06-24
US6979454B1 (en) 2005-12-27
EP0952819B1 (en) 2006-11-22
WO1997040818A1 (en) 1997-11-06
EP0952819A1 (en) 1999-11-03
DE69736985D1 (de) 2007-01-04

Similar Documents

Publication Publication Date Title
US7030104B2 (en) Topical oestroprogestational compositions with a systemic effect
ES2257428T3 (es) Composiciones farmaceuticas de liberacion sostenida para administracion parenteral de compuestos hidrofilos.
EP2961380B1 (en) Injectable long-acting local anesthetic semi-solid formulations and its compositions
ES2797376T3 (es) Composiciones para la administración transdérmica de inhibidores de mTOR
JPH02191214A (ja) 医薬活性剤の経皮デリバリー用組成物
WO1993000106A1 (en) External preparation containing cyclosporin
ES3039445T3 (en) Topical composition
KR20110090892A (ko) 두 개 이상의 침투 증강제의 조합으로 구성되는 국소 조성물
CN108159055A (zh) 治疗乳腺癌的长效递药系统、其制备方法及应用
ES2360469T3 (es) Composición farmacéutica que comprende un ungüento oleaginoso y dos principios activos en forma solubilizada.
ES2547556T3 (es) Emulsión de aceite en agua de mometasona y propilenglicol
JP4283892B2 (ja) 生物学的活性を有する組成物
KR19990087178A (ko) 병변조직 치료용 외용약제
ES2350798T3 (es) Composiciones farmacéuticas para uso oral para tratar a pacientes afectados por la obesidad.
ES2328814T3 (es) Mezclas eutecticas ternarias de anestesicos locales.
JP2024507011A (ja) エマルション組成物、ならびに放射線によって引き起こされる皮膚損傷の予防および/または処置におけるその使用
ES2538651T3 (es) Composiciones que comprenden compuestos de amonio cuaternario
JP2023538075A (ja) 長時間作用のインサイチュ形成/ゲル化組成物
JP2018016728A (ja) ゲル状組成物及びゲル状組成物の製造方法
ES2964513T3 (es) Fórmula farmacéutica tópica
WO2015158823A1 (de) Veterinärpharmazeutische zusammensetzung und deren verwendung
WO2010045700A1 (pt) Processo para preparação de formulação de suspensão veterinária para administração de medicamento insolúvel em água
JP2023120099A (ja) パンテノールを含有する軟膏剤
JPS6287528A (ja) N−アルキルモルホリン含有外皮投与用組成物
Jones Development of a Novel Implant for Drug Delivery